(Q36503291)

14 August 2017

Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study (English)

1 reference

14 August 2017

1 reference

1 reference

1 reference

1 reference

Silvia Sookoian

1

1 reference

14 August 2017

María Alejandra Fernández

series ordinal

2

1 reference

14 August 2017

Gustavo Castaño

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

48

1 reference

14 August 2017

7560-7563

1 reference

Evaluation of liver fibrosis: a concise review

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Collagen fibers, reticular fibers and elastic fibers. A comprehensive understanding from a morphological viewpoint

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Portal pressure response to losartan compared with propranolol in patients with cirrhosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727214

Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437678

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

NIH Consensus Statement on Management of Hepatitis C: 2002

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437678

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V11.I48.7560

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16437678

1 reference